Belimumab: review of use in systemic lupus erythematosus.
about
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Desensitization: Overcoming the Immunologic Barriers to TransplantationCharacterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies.Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.Neuropsychiatric Symptoms in LupusReflections on Lupus 2013: butterflies, wolves and prophecies.Cutaneous manifestations of systemic lupus erythematosus.Univariation and multiple linear regression analyses for 23 single nucleotide polymorphisms in 14 chronic glomerular disease's predisposing genes and systemic lupus erythematosus in Han Chinese.Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation.B-cell targeted therapeutics in clinical development.Nanomaterials, Autophagy, and Lupus Disease.Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials.Regulating STING in health and diseaseBelimumab for systemic lupus erythematosus: a practice-based view.
P2860
Q30276550-49E978F0-0F42-47A6-9602-66A7AC7385F0Q30397952-7D7A6C27-3667-48EB-9444-DB23B78ACA0AQ33659691-AAFC35F5-164B-4FF7-AA31-71EB1F19B145Q34273411-8F9A6118-B1DD-43EC-9DB0-17A725DAEECAQ34459628-18036766-8DB0-4963-83AA-F4182D1B89B0Q34976836-E2C7F7FB-8239-41EE-B6DD-C746591F1EB9Q36134951-3E92B861-67D6-495A-977C-0DE78A4E569CQ37498283-FACA13B9-31F6-4AD2-8322-57C7803C8300Q38068541-F6BBACDE-BFEF-432A-8B5A-C253499B72D4Q38097162-C0281C42-B306-43C3-8A76-5EEDA2CC0B86Q38551098-3A2D5F99-3D45-4CA5-AF1B-1857424D1AA9Q38840646-02AD2678-CA4C-4E76-8746-70125B1955E5Q39360861-7BAF42BA-B282-46F8-A943-01093EA38D98Q46364779-F9ABF7A2-627D-47A8-8309-062A49437164
P2860
Belimumab: review of use in systemic lupus erythematosus.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Belimumab: review of use in systemic lupus erythematosus.
@ast
Belimumab: review of use in systemic lupus erythematosus.
@en
Belimumab: review of use in systemic lupus erythematosus.
@nl
type
label
Belimumab: review of use in systemic lupus erythematosus.
@ast
Belimumab: review of use in systemic lupus erythematosus.
@en
Belimumab: review of use in systemic lupus erythematosus.
@nl
prefLabel
Belimumab: review of use in systemic lupus erythematosus.
@ast
Belimumab: review of use in systemic lupus erythematosus.
@en
Belimumab: review of use in systemic lupus erythematosus.
@nl
P1476
Belimumab: review of use in systemic lupus erythematosus.
@en
P2093
Bryan E Fusco
Eric G Boyce
P304
P356
10.1016/J.CLINTHERA.2012.02.028
P577
2012-03-30T00:00:00Z